These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 7502685

  • 21. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG, Erb K, Laursen S, Rasmussen PE, Rex S.
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Atypical response to luteinizing hormone-releasing hormone (LH-RH) agonist (suprefact nasal) in induction of ovulation in in vitro fertilization (IVF).
    Lessing JB, Cohen JR, Yovel I, Amit A, David MP, Peyser MR.
    J In Vitro Fert Embryo Transf; 1991 Dec; 8(6):314-6. PubMed ID: 1770271
    [Abstract] [Full Text] [Related]

  • 24. Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilization.
    Avrech OM, Orvieto R, Pinkas H, Sapir-Rufas O, Feldberg D, Fisch B.
    Gynecol Endocrinol; 2004 Nov; 19(5):247-52. PubMed ID: 15726912
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
    Acosta AA, Bernardus RE, Jones GE, Garcia J, Rosenwaks Z, Simonetti S, Veeck LL, Jones D.
    Acta Eur Fertil; 1985 Nov; 16(2):81-99. PubMed ID: 3929523
    [Abstract] [Full Text] [Related]

  • 29. The impact of adding hp-hMG in r-FSH started GnRH antagonist cycles on ART outcome.
    Kan O, Simsir C, Atabekoglu CS, Sonmezer M.
    Gynecol Endocrinol; 2019 Oct; 35(10):869-872. PubMed ID: 30973022
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.
    van de-Helder AB, Helmerhorst FM, Blankhart A, Brand R, Waegemaekers C, Naaktgeboren N.
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):358-62; discussion 363-4. PubMed ID: 2127604
    [Abstract] [Full Text] [Related]

  • 33. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
    Cassidenti DL, Paulson RJ, Lobo RA, Sauer MV.
    Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.
    Lanzone A, Fulghesu AM, Spina MA, Apa R, Menini E, Caruso A, Mancuso S.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1253-8. PubMed ID: 3119655
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP, Macklon NS, Fauser BC.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, Lainas TG.
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.